Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,193506138153437433
Market Cap Growth
523.30%266.35%-9.38%-65.05%0.75%-
Enterprise Value
71433910829341225
Last Close Price
19.4213.0822.2045.00133.00232.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.081.431.011.742.00
P/TBV Ratio
--1.431.011.742.00

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-0.020.330.240.160.08
Net Debt / Equity Ratio
3.492.75-0.62-0.67-0.76-0.88
Net Debt / EBITDA Ratio
3.241.330.510.832.112.80
Net Debt / FCF Ratio
4.003.150.601.002.042.59
Quick Ratio
13.2518.094.948.8117.5520.43
Current Ratio
13.5018.205.199.0418.0621.12
Return on Equity (ROE)
---94.52%-58.74%-39.45%-52.09%
Return on Assets (ROA)
-27.45%-70.41%-44.42%-31.67%-21.55%-27.09%
Return on Capital Employed (ROCE)
-32.10%-77.90%-97.50%-69.00%-32.60%-29.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
157.12%-137.42%-84.57%-77.25%-21.09%-15.90%
FCF Yield
-10.03%-28.36%-72.25%-66.44%-21.44%-16.86%
Buyback Yield / Dilution
-682.04%-187.35%-2.26%-69.88%-18.30%-15547.86%
SEC Filings: 10-K · 10-Q